Q1 EPS Estimate for Mirum Pharmaceuticals Cut by Analyst
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Investment analysts at Leerink Partnrs decreased their Q1 2025 earnings per share (EPS) estimates for Mirum Pharmaceuticals in a report released on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings per share of ($0.51) for the quarter, down from […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Investment analysts at Leerink Partnrs decreased their Q1 2025 earnings per share (EPS) estimates for Mirum Pharmaceuticals in a report released on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings per share of ($0.51) for the quarter, down from […]
